Cardio-Oncology

This track can focus on the intersection of cardiovascular disease and cancer, including the cardiotoxic effects of cancer therapies (chemotherapy, radiation), risk stratification, prevention, and management of cardiovascular complications in cancer patients and survivors. Strategies for cardiovascular risk assessment and risk stratification in cancer patients before, during, and after cancer treatment. This includes pre-treatment cardiovascular evaluation, assessment of baseline cardiac function, identification of pre-existing cardiovascular risk factors, and monitoring for cardiotoxicity during cancer therapy.

 

    Related Conference of Cardio-Oncology

    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Cardio-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in